451 related articles for article (PubMed ID: 9525831)
1. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas.
Barth RF
J Neurooncol; 1998 Jan; 36(1):91-102. PubMed ID: 9525831
[TBL] [Abstract][Full Text] [Related]
2. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.
Barth RF; Kaur B
J Neurooncol; 2009 Sep; 94(3):299-312. PubMed ID: 19381449
[TBL] [Abstract][Full Text] [Related]
3. Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.
Sahu U; Barth RF; Otani Y; McCormack R; Kaur B
J Neuropathol Exp Neurol; 2022 Apr; 81(5):312-329. PubMed ID: 35446393
[TBL] [Abstract][Full Text] [Related]
4. Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental malignant gliomas.
Lefranc F; Sadeghi N; Metens T; Brotchi J; Salmon I; Kiss R
Neurosurgery; 2003 Apr; 52(4):881-90; discussion 890-1. PubMed ID: 12657185
[TBL] [Abstract][Full Text] [Related]
5. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma.
Kruse CA; Molleston MC; Parks EP; Schiltz PM; Kleinschmidt-DeMasters BK; Hickey WF
J Neurooncol; 1994; 22(3):191-200. PubMed ID: 7760095
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.
Bouchet A; Bidart M; Miladi I; Le Clec'h C; Serduc R; Coutton C; Regnard P; Khalil E; Dufort S; Lemasson B; Laissue J; Pelletier L; Le Duc G
Tumour Biol; 2014 Jul; 35(7):6221-33. PubMed ID: 24633919
[TBL] [Abstract][Full Text] [Related]
7. [Schmidt Ruppin-D-ASV-induced primary rat brain tumor model for therapeutic screening].
Nakamura O; Hojo S; Takakura K; Nagashima K; Ishizaki R
No To Shinkei; 1982 Jul; 34(7):691-7. PubMed ID: 6291561
[TBL] [Abstract][Full Text] [Related]
8. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
[TBL] [Abstract][Full Text] [Related]
9. Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors.
Tzeng JJ; Barth RF; Orosz CG; James SM
Cancer Res; 1991 May; 51(9):2373-8. PubMed ID: 2015600
[TBL] [Abstract][Full Text] [Related]
10. Effects of syngeneic cellular vaccinations alone or in combination with GM-CSF on the weakly immunogenic F98 glioma model.
Clavreul A; Delhaye M; Jadaud E; Menei P
J Neurooncol; 2006 Aug; 79(1):9-17. PubMed ID: 16575532
[TBL] [Abstract][Full Text] [Related]
11. Human and rat glioma growth, invasion, and vascularization in a novel chick embryo brain tumor model.
Cretu A; Fotos JS; Little BW; Galileo DS
Clin Exp Metastasis; 2005; 22(3):225-36. PubMed ID: 16158250
[TBL] [Abstract][Full Text] [Related]
12. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
13. Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.
Parsa AT; Chakrabarti I; Hurley PT; Chi JH; Hall JS; Kaiser MG; Bruce JN
Neurosurgery; 2000 Oct; 47(4):993-9; discussion 999-1000. PubMed ID: 11014444
[TBL] [Abstract][Full Text] [Related]
14. Can experimental models of rodent implantation glioma be improved? A study of pure and mixed glioma cell line tumours.
Whittle IR; Macarthur DC; Malcolm GP; Li M; Washington K; Ironside JW
J Neurooncol; 1998 Feb; 36(3):231-42. PubMed ID: 9524101
[TBL] [Abstract][Full Text] [Related]
15. A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization.
Caplan J; Pradilla G; Hdeib A; Tyler BM; Legnani FG; Bagley CA; Brem H; Jallo G
Neurosurgery; 2006 Jul; 59(1):193-200; discussion 193-200. PubMed ID: 16823316
[TBL] [Abstract][Full Text] [Related]
16. Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas.
Graf MR; Sauer JT; Merchant RE
J Neurooncol; 2005 May; 73(1):29-36. PubMed ID: 15933813
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Allogeneic and Syngeneic Rat Glioma Models by Using MRI and Histopathologic Evaluation.
Biasibetti E; Valazza A; Capucchio MT; Annovazzi L; Battaglia L; Chirio D; Gallarate M; Mellai M; Muntoni E; Peira E; Riganti C; Schiffer D; Panciani P; Lanotte M
Comp Med; 2017 Mar; 67(2):147-156. PubMed ID: 28381315
[TBL] [Abstract][Full Text] [Related]
18. Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography.
Doblas S; He T; Saunders D; Pearson J; Hoyle J; Smith N; Lerner M; Towner RA
J Magn Reson Imaging; 2010 Aug; 32(2):267-75. PubMed ID: 20677250
[TBL] [Abstract][Full Text] [Related]
19. A novel brainstem tumor model: functional and histopathological characterization.
Jallo GI; Volkov A; Wong C; Carson BS; Penno MB
Childs Nerv Syst; 2006 Dec; 22(12):1519-25. PubMed ID: 17021732
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
